Citations for
MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.
Guijarro MV, Link W, Rosado A, Leal JF, Carnero A.
Carcinogenesis 28(12):2443-50. Epub 2007 Aug 3. 2007
MAP17 enhances the malignant behavior of tumor cells through ROS increase.
Guijarro MV, Leal JF, Blanco-Aparicio C, Alonso S, Fominaya J, Lleonart M, Castellvi J, Ramon y Cajal S, Carnero A.
Carcinogenesis 28(10):2096-104. Epub 2007 Jun 4. 2007
MAP17 overexpression is a common characteristic of carcinomas.
Guijarro MV, Leal JF, Fominaya J, Blanco-Aparicio C, Alonso S, Lleonart M, Castellvi J, Ruiz L, Ramon Y Cajal S, Carnero A.
Carcinogenesis 28(8):1646-52. Epub 2007 Apr 9. 2007
Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest.
Guijarro MV, Castro ME, Romero L, Moneo V, Carnero A.
J Cell Biochem 101(1):112-21. 2007
Identification of small PDZK1-associated protein, DD96/MAP17, as a regulator of PDZK1 and plasma high density lipoprotein levels.
Silver DL, Wang N, Vogel S.
J Biol Chem 278(31):28528-32. Epub 2003 May 15. 2003
From the Cover: Regulation of the stem cell leukemia (SCL) gene: a tale of two fishes.
Barton LM, Gottgens B, Gering M, Gilbert JG, Grafham D, Rogers J, Bentley D, Patient R, Green AR.
Proc Natl Acad Sci U S A 98(12):6747-52. 2001
Identification and partial characterization of a novel membrane-associated protein (MAP17) up-regulated in human carcinomas and modulating cell replication and tumor growth.
Kocher O, Cheresh P, Lee SW.
Am J Pathol 149(2):493-500. 1996
Identification of a novel gene, selectively up-regulated in human carcinomas, using the differential display technique.
Kocher O, Cheresh P, Brown LF, Lee SW.
Clin Cancer Res 1(10):1209-15. 1995